Many enjoy the 40-60% efficacy of protection offered by the influenza vaccine without issue, but some patients do experience complications. With the National Vaccine Injury Compensation Program, it is possible to receive compensation for your flu shot injury.
The CDC recommends that children receive the first dose of the MMR vaccination from 12-15 months, and the second dose at 4-6 years. Adults born after 1956 who have not been vaccinated should receive at least one dose of the vaccine, but how does it protect us?
Influenza, or the flu, is a contagious respiratory illness caused by a viral infection of the nose, throat, and lungs. The virus travels from person to person through infectious droplets expelled from the nose or mouth, but chances of contracting the virus decrease between 40-60% with the administration of a flu shot.
New to vaccine injury litigation? Good news – we’re not! Learn about the National Vaccine Injury Compensation program and how you may be eligible to receive compensation for your vaccine injury claim:
Herd Immunity is a phenomena seen when a high percentage of individuals within a population have developed immunity to a pathogen. Because so many people within the community are unable to contract the disease or virus, this reduces the likelihood that those who have not developed immunity will contract the disease.
Influenza, better known as the flu, is a highly contagious virus that attacks the respiratory system. The virus is passed from person to person though respiratory droplets emitted when an infected person talks, sneezes, or coughs. People find themselves at risk for contracting the flu when inhaling the infected droplets or touching their eyes, mouth or nose after touching something that has been infected.
DTaP is a vaccine given to infants and young children and is administered in 5 separate shots. Licensed in 2005, the CDC estimates that these vaccines will prevent 732,000 deaths of children born between 1994 and 2013. The vaccination protects against Diphtheria, Tetanus, and Pertussis.
Research and case studies suggest that SIRVA is caused by improper administration of the vaccine, rather than the vaccine components. It is recommended that injections be administered into the deltoid muscle in the upper arm for adults. However, even trained medical professionals can misjudge the placement of an injection, placing it too high or too deep, outside of the recommended injection site.
